Literature DB >> 31853612

High-resolution Compressed-sensing T1 Black-blood MRI : A New Multipurpose Sequence in Vascular Neuroimaging?

Konstanze Guggenberger1, Axel Joachim Krafft2, Ute Ludwig2, Patrick Vogel3, Samer Elsheik4, Esther Raithel5, Christoph Forman5, Philippe Dovi-Akué4, Horst Urbach4, Thorsten Bley3, Stephan Meckel4.   

Abstract

BACKGROUND AND
PURPOSE: In vasculopathies of the central nervous system, reliable and timely diagnosis is important against the background of significant morbidity and sequelae in cases of incorrect diagnosis or delayed treatment. Magnetic resonance imaging (MRI) plays a major role in the detection and monitoring of intracranial and extracranial vascular pathologies of different etiologies, in particular for evaluation of the vessel wall in addition to luminal information, thus allowing differentiation between various vasculopathies. Compressed-sensing black-blood MRI combines high image quality with relatively short acquisition time and offers promising potential in the context of neurovascular vessel wall imaging in clinical routine. This case review gives an overview of its application in the diagnosis of various intracranial and extracranial entities.
METHODS: An optimized high-resolution compressed-sensing black-blood 3D T1-weighted fast (turbo) spin echo technique (T1 CS-SPACE prototype) precontrast and postcontrast application at 3T was used for the evaluation of various vascular conditions in neuroradiology.
RESULTS: In this article seven cases of intracranial and extracranial arterial and venous vasculopathies with representative imaging findings in high-resolution compressed-sensing black-blood MRI are presented.
CONCLUSION: High-resolution 3D T1 CS-SPACE black-blood MRI is capable of imaging various vascular entities in high detail with whole head coverage and low susceptibility for motion artifacts and within acceptable scan times. It represents a highly versatile, non-invasive technique for the visualization and differentiation of a wide variety of neurovascular arterial and venous disorders.

Entities:  

Keywords:  Giant cell arteritis; Large vessel vasculitis; MRI; Vasculitis; Vessel wall imaging

Year:  2019        PMID: 31853612     DOI: 10.1007/s00062-019-00867-0

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  5 in total

1.  Idiopathic intracranial hypertension - a wider spectrum than headaches and blurred vision.

Authors:  H Urbach; I E Duman; D M Altenmüller; C Fung; N Lützen; S Elsheikh; J Beck
Journal:  Neuroradiol J       Date:  2021-08-11

Review 2.  Current Clinical Applications of Intracranial Vessel Wall MR Imaging.

Authors:  Raghav R Mattay; Jose F Saucedo; Vance T Lehman; Jiayu Xiao; Emmanuel C Obusez; Scott B Raymond; Zhaoyang Fan; Jae W Song
Journal:  Semin Ultrasound CT MR       Date:  2021-08-01       Impact factor: 1.641

Review 3.  Characteristics of symptomatic plaque on high-resolution magnetic resonance imaging and its relationship with the occurrence and recurrence of ischemic stroke.

Authors:  Jie-Ji Zhao; Yue Lu; Jun-Yi Cui; Lin-Qing Ma; Run-Ping Zhang; Zhuan Xu
Journal:  Neurol Sci       Date:  2021-07-08       Impact factor: 3.307

4.  High-Resolution Gadolinium-Enhanced MR Cisternography Using Compressed-Sensing T1 SPACE Technique for Detection of Intracranial CSF Leaks.

Authors:  I E Duman; T Demerath; A Stadler; S Elsheikh; E Raithel; C Forman; T Hildenbrand; M Shah; J Grauvogel; C Scheiwe; H Urbach; S Meckel
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-29       Impact factor: 3.825

5.  Vasa vasorum of proximal cerebral arteries after dural crossing - potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI.

Authors:  Stephan Meckel; Thorsten Alexander Bley; Konstanze Viktoria Guggenberger; Giulia Dalla Torre; Ute Ludwig; Patrick Vogel; Andreas Max Weng; Marius Lothar Vogt; Matthias Fröhlich; Marc Schmalzing; Esther Raithel; Christoph Forman; Horst Urbach
Journal:  Eur Radiol       Date:  2021-08-04       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.